ONO-7913-04: ONO-7913 Phase 1 Study

ABSTRACT: Interventions: Administration of ONO-7913 and ONO-4538 with FOLFOX and Bevacizumab or Cetuximab Primary outcome(s): Tolerability, safety Study Design: non-randomized controlled trial, open(masking not used), uncontrolled control, single assignment, treatment purpose

DISEASE(S): Unresectable Advanced Or Recurrent Colorectal Cancer

PROVIDER: 2613449 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR